- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about ketamine
Recent news which mentions ketamine
Psychedelics In Mexico: Are They Legal? Well, Yes And No
December 10, 2023
Tickers
DMT
From Benzinga
Awakn Life Sciences Submits CTA For Phase III Alcohol Use Disorder Clinical Trial
September 06, 2023
Tickers
AWKNF
From Benzinga
Treating PTSD Topically & Directly To The Brain? Psychedelics Delivery Company Poised For Major Breakthrough
September 03, 2023
Tickers
BWVI
From Benzinga
Elon Musk's Use Of Ketamine May Contribute To Erratic Behavior, Says Ronan Farrow: 'Led To Him At Times Talking About His Loneliness...'
August 24, 2023
Tickers
TECH
From Benzinga
Legal Psychedelics: Which Compounds Will Be Approved Next? MDMA, LSD Or Something Else?
August 20, 2023
Tickers
MDMA
From Benzinga
A Quantum Leap In Psychedelic Research: Study Shows Real-Time Brain Changes After Ketamine Use
July 21, 2023
Tickers
CYBN
From Benzinga
Elon Musk 'Microdoses' On Ketamine For Depression: WSJ
June 27, 2023
From Benzinga
From Benzinga
From Benzinga
PharmaTher Seeks Regulatory Approval Of New Ketamine Delivery System For Anesthesia And Sedation
February 07, 2023
Tickers
PHRRF
From Benzinga
From Benzinga
Exclusive: New Latin American JV To Provide More Psychedelic Medical Treatments For Mental Health Conditions
November 22, 2022
From Benzinga
Zappy Zapolin Believes Psychedelic Research Has Come Of Age
October 30, 2022
From Benzinga
Mental Health Provider Expands Psychedelic-Assisted Therapy For Chronic & Serious Medical Illnesses
October 28, 2022
Tickers
NUMIF
From Benzinga
Atai's Phase 2 Study For Treatment-Resistant Depression Completes Enrollment, Expects Results Soon
October 26, 2022
Tickers
ATAI
From Benzinga
Treating Postpartum Depression With Cannabis Or Psychedelics Like Ketamine And MDMA: Does It Work?
October 21, 2022
From Benzinga
Elon Musk's 'Exploratory Journeys' And Charts Explaining Benefits Of Psychedelics Over Alcohol
October 11, 2022
Tickers
TSLA
From Benzinga
Ketamine Telehealth: Is It Safe? Is It Here To Stay?
October 08, 2022
From Benzinga
Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option
October 05, 2022
From Benzinga
Psyched: Autopsy Reveals Death By Ketamine, LSD-Like Drugs Without Hallucinations, DEA & Right To Try Psilocybin
September 30, 2022
From Benzinga
Amended Autopsy Finds Elijah McClain Died From Ketamine Injected By Paramedics Called By Cops
September 26, 2022
From Benzinga
Nova Vita Redefines Longevity With Innovative Wellness Solutions
September 20, 2022
From PRUnderground
PharmaTher Presents Positive Data On Ketamine For Treatment Of Dyskinesia In Parkinson's Disease
September 17, 2022
Tickers
PHRRF
From Benzinga
Wellbeing Digital Reports 4Q Finances, 'Three Key Pillars' Stay Strong
September 16, 2022
Tickers
KONEF
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.